Manzo Pharmaceuticals, Inc.
MNZO
$0.0001
$0.000.00%
OTC PK
| 09/30/2005 | 06/30/2005 | 03/31/2005 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | 195.69% | -96.74% | -- | ||
| Gross Profit | -195.69% | -302.05% | -- | ||
| SG&A Expenses | -6.93% | 58.12% | 74.16% | ||
| Depreciation & Amortization | -6.38% | -82.79% | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 10.51% | -69.78% | 112.81% | ||
| Operating Income | -10.51% | -29.91% | -112.81% | ||
| Income Before Tax | -20.28% | -11.00% | 1,298.23% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -20.28% | -11.00% | 1,298.23% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -20.28% | -11.00% | 1,298.23% | ||
| EBIT | -10.51% | -29.91% | -112.81% | ||
| EBITDA | -11.22% | -43.38% | -203.10% | ||
| EPS Basic | 19.86% | -7.14% | 1,258.65% | ||
| Normalized Basic EPS | 25.74% | -15.71% | 272.82% | ||
| EPS Diluted | 20.37% | -10.89% | 1,100.00% | ||
| Normalized Diluted EPS | 25.80% | -15.71% | 259.98% | ||
| Average Basic Shares Outstanding | 50.09% | 3.59% | 3.41% | ||
| Average Diluted Shares Outstanding | 50.17% | 3.59% | 11.70% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||